The prognostic value of maturation-associated phenotypic abnormalities in myelodysplastic syndromes

被引:12
作者
Lorand-Metze, I. [1 ]
Califani, S. M. V. [1 ]
Ribeiro, E. [1 ]
Lima, C. S. P. [1 ]
Metze, K. [1 ]
机构
[1] Univ Estadual Campinas, Fac Med, BR-13081970 Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
myelodysplastic syndromes; cell maturation; phenotypic aberrations; flow cytometry; prognosis;
D O I
10.1016/j.leukres.2007.06.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several phenotypic abnormalities of bone marrow (BM) hemopoietic precursors have been associated with disease progression in myelodysplastic syndromes (MDS). We analyzed the influence on overall survival of the expression of lineage and maturation-associated antigens of BM hemopoietic cells quantified in a previous study. In the univariate Cox regression the peripheral platelet count was a significant favourable factor for overall survival. Unfavorable prognostic factors were: WPSS, increase in BM CD34+ cells, increased mean fluorescence intensity (MFI) of CD13 on myelocytes, metamyelocytes and mature neutrophils as well as increased CD45 of myelocytes and mature neutrophils. In a model containing platelet count, WPSS and MFI of CD45 and CD13 on mature neutrophils, only hyperexpression of CD13 and degree of thrombocytopenia were independent risk factors. Therefore, phenotypic features that can also be obtained from PB might be useful for predicting Survival in MDS. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:211 / 213
页数:3
相关论文
共 50 条
  • [21] The Prognostic Value of Pretherapy Peripheral Blood Inflammatory Indices in Myelodysplastic Syndromes
    Shi, Cong
    Gong, Shengping
    Niu, Tingting
    Li, Tongyu
    Wu, An
    Zheng, Xiaojiao
    Yang, Shujun
    Ouyang, Guifang
    Mu, Qitian
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] PROGNOSTIC FACTORS IN THE MYELODYSPLASTIC SYNDROMES
    TRICOT, GJ
    LEUKEMIA RESEARCH, 1992, 16 (01) : 109 - 115
  • [23] Prognostic models in myelodysplastic syndromes
    Bejar, Rafael
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2013, : 504 - 510
  • [24] Chromosome and molecular abnormalities in myelodysplastic syndromes
    Fenaux, P
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2001, 73 (04) : 429 - 437
  • [25] Chromosome and Molecular Abnormalities in Myelodysplastic Syndromes
    Pierre Fenaux
    International Journal of Hematology, 2001, 73 : 429 - 437
  • [26] Impact of immunophenotype on prognosis of patients with myelodysplastic syndromes.: Its value in patients without karyotypic abnormalities
    Arroyo, JL
    Fernández, ME
    Hernández, JIM
    Orfao, A
    San Miguel, JF
    del Cañizo, MC
    HEMATOLOGY JOURNAL, 2004, 5 (03) : 227 - 233
  • [27] Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes
    Chu, Sung-Chao
    Wang, Tso-Fu
    Li, Chi-Cheng
    Kao, Ruey-Ho
    Li, Dian-Kun
    Su, Yu-Chieh
    Wells, Denise A.
    Loken, Michael R.
    LEUKEMIA RESEARCH, 2011, 35 (07) : 868 - 873
  • [28] Autoimmune disorders associated with myelodysplastic syndromes: clinical, prognostic and therapeutic implications
    Fozza, Claudio
    Murtas, Andrea
    Caocci, Giovanni
    La Nasa, Giorgio
    LEUKEMIA RESEARCH, 2022, 117
  • [29] Altered neutrophil maturation patterns that limit identification of myelodysplastic syndromes
    Monaghan, Sara A.
    Surti, Urvashi
    Doty, Ketah
    Craig, Fiona E.
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2012, 82B (04) : 217 - 228
  • [30] Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation
    Wang, Hong
    Qi, Jiaqian
    Li, Xueqian
    Chu, Tiantian
    Qiu, Huiying
    Fu, Chengcheng
    Tang, Xiaowen
    Ruan, Changgeng
    Wu, Depei
    Han, Yue
    FRONTIERS IN ONCOLOGY, 2022, 12